MYO9B and breast carcinoma: Finally, only 1 (BCAS4/BCAS3), 1 (BSG/NFIX), 2 (STX16/RAE1, RAB22A/MYO9B) and 0 fusions have been reported by all the tools within the considered breast cancer cell lines.